Therapeutic Solutions International, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Therapeutic Solutions International, Inc. announces its intention to voluntarily withdraw its common stock from listing and registration on the OTC Markets.
OTC.Pink
Therapeutic Solutions International (TSOI) is offering a one-time loyalty dividend to its shareholders in the form of Breathe Biologics (BRTH) shares.
OTC.Pink
Therapeutic Solutions International (TSOI) will issue a one-time loyalty dividend of Breathe Biologics (BRTH) shares to TSOI shareholders.
OTC.Pink
Therapeutic Solutions International has increased its authorized share count from 6.5 billion to 9 billion common shares and authorized 5 million preferred shares after receiving shareholder approval.
OTC.Pink
Therapeutic Solutions International has initiated a civil action against the University of Miami and others in the Southern District of California.
OTC.Pink
Therapeutic Solutions International has extended the deadline for shareholders to elect to receive a loyalty dividend in the form of Campbell Neurosciences, Inc. shares to September 30, 2024.
OTC.Pink
Therapeutic Solutions International is addressing confusion surrounding its elective loyalty dividend of Campbell Neurosciences shares, urging shareholders to contact their brokers to ensure proper election by the August 14, 2024 deadline.
OTC.Pink
Therapeutic Solutions International's partially owned subsidiary, Campbell Neurosciences, Inc., has entered into an exclusive patent license agreement.
OTC.Pink
Therapeutic Solutions International's partially owned subsidiary, Campbell Neurosciences, Inc., has entered into an exclusive patent license agreement.
OTC.Pink
8-K: Therapeutic Solutions International Announces Loyalty Dividend of Campbell Neurosciences Shares
Therapeutic Solutions International (TSOI) is offering a loyalty dividend of Campbell Neurosciences (CNSI) shares to its shareholders, after withdrawing a previous attempt due to staleness.
OTC.Pink
8-K: Therapeutic Solutions International Increases Authorized Share Count Following Shareholder Approval
Therapeutic Solutions International has increased its authorized share capital from 5.5 billion to 6.5 billion shares after receiving shareholder consent.
OTC.Pink
Therapeutic Solutions International has filed a Certificate of Change to create a new series of preferred stock, designated Series B 5% Preferred Stock.
OTC.Pink
Therapeutic Solutions International has filed a civil action against operators of online message boards, alleging they facilitate fraud and market manipulation.